Hydroxyzine Hydrochloride Tablet, Film Coated
Product Images NDC 70518-2066

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Hydrochloride (NDC 70518-2066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Hydroxyzine HCl 25mg 70518 2066 00

Hydroxyzine HCl 25mg 70518 2066 00
This is a description of a medication called Hydroxyzine HCI. It is a tablet with a dosage strength of 25 mg. The package contains 30 tablets. It is RX only, which means it requires a prescription. The NDC number for this medication is 70518-2066-00. The lot number and expiration date are not provided. The medication was sourced from NDC 00093-5061-01, manufactured by Teva Pharma in North Wales, PA 19454. It is important to keep this medication out of the reach of children. The directions for use can be found in the package insert. The recommended storage temperature is between 20-25°C (88-77°F), with excursions permitted between 15-30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc. in Indiana, PA 15701. Their contact number is 724.465.8762.*
FDA Label Image

Image 1

Image 1

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.